Unasyn and Agranulocytosis - a phase IV clinical study of FDA data
Summary:
Agranulocytosis is reported as a side effect among people who take Unasyn (ampicillin sodium; sulbactam sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zofran, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Agranulocytosis when taking Unasyn. It is created by eHealthMe based on reports of 4,454 people who have side effects when taking Unasyn from the FDA, and is updated regularly.
What is Unasyn?
Unasyn has active ingredients of ampicillin sodium; sulbactam sodium. eHealthMe is studying from 4,474 Unasyn users. Check the latest studies of Unasyn.
What is Agranulocytosis?
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,327 drugs and 3,591 conditions by eHealthMe. Check the latest studies of Agranulocytosis.
4,454 people reported to have side effects when taking Unasyn.
Among them, 139 people (3.12%) have Agranulocytosis.
Among these 139 people:
How long have people been on Unasyn when they have Agranulocytosis? *
What is the gender of people who have Agranulocytosis when taking Unasyn? *
What is the age of people who have Agranulocytosis when taking Unasyn? *
What are other drugs people take besides Unasyn? *
What are other side effects people have besides Agranulocytosis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Unasyn and have Agranulocytosis?
- Check whether Agranulocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Unasyn:
- Unasyn (4,474 reports)
Agranulocytosis treatments and more:
- Agranulocytosis (213,267 reports)
How severe was Agranulocytosis and when was it recovered:
Expand to all the drugs that have ingredients of ampicillin sodium; sulbactam sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Unasyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Agranulocytosis:
- Agranulocytosis (2,327 drugs)
Browse all the conditions that are associated with Agranulocytosis:
- Agranulocytosis (3,591 conditions)
Related publications that referenced our studies
- Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
- Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ampicillin sodium; sulbactam sodium (the active ingredients of Unasyn) and Unasyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Paclitaxel cause Skin Exfoliation? - 6 seconds ago
- Could Arimidex cause Acne? - 7 seconds ago
- Drug interactions of Acetaminophen And Codeine Phosphate and Remicade - 8 seconds ago
- Drug interactions of Acetaminophen And Codeine Phosphate and Rabeprazole Sodium - 9 seconds ago
- Could Lactobacillus Rhamnosus cause Dizziness Aggravated? - 16 seconds ago
- Drug interactions of Renagel and Lidocaine - 37 seconds ago
- How effective is Relafen for Arthritis? - 37 seconds ago
- Methotrexate Preservative Free vs. Remicade, side effect and effectiveness comparison - 54 seconds ago
- Drug interactions of Metrolotion and Macrobid - 54 seconds ago
- Drug interactions of Varenicline Tartrate and Ergocalciferol - a minute ago